adamantane has been researched along with thioctic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, H; Wang, W; Wang, X; Xu, W; Zhang, D | 1 |
Fang, F; Huang, Y; Li, W; Liao, Q; Liao, X; Liu, X; Long, M; Ouyang, Q; Rojo de la Vega, M; Tang, Z; Tong, Q; Wang, H; Wang, X; Wang, Y; Yu, S; Zhang, DD; Zhang, L; Zhang, R; Zheng, H; Zheng, Y | 1 |
2 other study(ies) available for adamantane and thioctic acid
Article | Year |
---|---|
Pharmacokinetics of lipoyl vildagliptin, a novel dipeptidyl peptidase IV inhibitor after oral administration in rats.
Topics: Adamantane; Administration, Oral; Animals; Chromatography, Liquid; Dipeptidyl-Peptidase IV Inhibitors; Male; Mass Spectrometry; Nitriles; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thioctic Acid; Vildagliptin | 2010 |
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis.
Topics: Adamantane; Animals; Antioxidants; Biomarkers, Tumor; Cell Line, Tumor; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Glutamate-Cysteine Ligase; Humans; Hypoglycemic Agents; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Mice; Neoplasm Metastasis; NF-E2-Related Factor 2; Risk Factors; Signal Transduction; Sitagliptin Phosphate; Thioctic Acid; Ubiquitination | 2016 |